Dr John Edgar Lewis, MD | |
65 Medical Park Blvd, Suite 103, Pineville, LA 71360-8428 | |
(318) 484-2951 | |
(318) 484-2951 |
Full Name | Dr John Edgar Lewis |
---|---|
Gender | Male |
Speciality | Dermatology |
Location | 65 Medical Park Blvd, Pineville, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710081393 | NPI | - | NPPES |
1970271 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 3019 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Edgar Lewis, MD 65 Medical Park Blvd, Suite 103, Pineville, LA 71360-8428 Ph: (318) 484-2951 | Dr John Edgar Lewis, MD 65 Medical Park Blvd, Suite 103, Pineville, LA 71360-8428 Ph: (318) 484-2951 |
News Archive
Several physicians at Rutgers Cancer Institute of New Jersey have been named as a 'Top Doctor' by Inside Jersey magazine.
Scientists have discovered how tendons - the fibrous tissue that connects muscle to bone - become damaged through injury or the ageing process in what could lead to new treatments for people with tendon problems.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.
Rani Therapeutics announced today that it has entered into a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, to evaluate Rani's novel oral drug delivery platform. The companies have agreed to conduct feasibility studies over the next two years, in which Rani will test select biologic molecules in the area of metabolic disease to evaluate the oral delivery of these molecules.
Big changes are coming to the US health care system—some in response to the mounting scrutiny of medical imaging. New task force recommendations, the Choosing Wisely campaign, and Affordable Care Act policies are all attempting to curtail overtesting—with CT scans, MRIs and any other screening often ordered unnecessarily—that can drive up medical costs, lead to waste and unnecessary radiation, and prompt undue anxiety about false positive results.
› Verified 8 days ago